Announcements Trials

Browse Landscape

Phase

Phase NA 4 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1 Gynecologic Cancer 1 Esophageal Neoplasms 1

Interventions

Oxaliplatin 56 Capecitabine 49 Fluorouracil 37 Cisplatin 37 S 1 (combination) 23 Paclitaxel 18 Docetaxel 18 Leucovorin 16 pembrolizumab 13 Irinotecan 12 apatinib 11 titanium silicide 9 XELOX 9 Trastuzumab 9 Nivolumab 9 Hyperthermic Intraperitoneal Chemotherapy 8 Epirubicin 8 Drug Therapy 8 Tegafur 7 Radiotherapy 6 Neoadjuvant Therapy 6 gimeracil 5 Surgical Procedures, Operative 5 Gastrectomy 5 Chemotherapy, Adjuvant 5 tislelizumab 4 S-1 plus cisplatin 4 Ramucirumab 4 zolbetuximab 3 sintilimab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Stomach Neoplasms × Preoperative Exercise × Clear all

NCT02780921 2017-01-25

PREHAB

University Hospital, Clermont-Ferrand

Phase 3 Unknown

Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡